Stereotaxis (STXS) Swings to Q3 Loss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Stereotaxis Reports 2015 Third Quarter Financial Results
November 3, 2015 4:05 PM EST-Total Quarterly Revenue Increased 5% Year over Year on Improved System and Recurring Revenues- -Total Revenue for First Nine Months Increased 13% Year over Year to $28.5 Million- -System Revenue for First Nine Months Increased 76% Year over Year to $8.2 Million- -Operating Loss Decreased 23% Year over Year and 29% for the First Nine-Month Period--Third Niobe® ES System Shipment to Japan--New System Automation Features Released--Conference Call Today at 4:30 p.m. Eastern Time-
ST. LOUIS, Nov. 03, 2015 (GLOBE NEWSWIRE) -- Stereotaxis, Inc. (NASDAQ: STXS), a global leader in innovative technologies for the treatment of cardiac arrhythmias,... More
